Disclaimer :
This Product Image is the Property of Arvantis Pharmaceuticals. Using this Product Image Without Prior Permission is Prohibited and Ignoring this Request May Lead to Legal Consequences.
Composition
Controlled Release Tablets of Sodium Valproate & Valproic Acid
Description
ARV-PORATE-200 CR (Controlled Release Tablets of Sodium Valproate & Valproic Acid) is an antiepileptic medicine used for the management of epilepsy, seizure disorders, and bipolar disorder, as well as for the prevention of migraine headaches. Its controlled-release formulation helps maintain consistent drug levels, providing prolonged therapeutic action and improved seizure control. Manufactured under stringent quality standards, Arvantis Pharmaceuticals ensures safe, effective, and reliable tablets with consistent therapeutic performance. These tablets are ideal for PCD Pharma Franchise, third-party manufacturing, hospital supply, institutional procurement, and bulk distribution across Delhi and India.
Enter your details to start WhatsApp chat
Tablets
Capsules
Softgels
Syrups & Susp.
Injectables
Drops
Cream-lotions
Dry Syrups
Others
